REGEN BIOPHARMA, INC. (RGBPP) Net income 2017–2026
REGEN BIOPHARMA, INC. (RGBPP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$1.3MFY2026 · since FY2017: -$7.8M → -$1.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$1.3M | -90.7% |
| FY2025 | -$668,255 | -157.8% |
| FY2024 | $1.2M | -52.7% |
| FY2023 | $2.4M | +136.1% |
| FY2022 | -$6.8M | -298.1% |
| FY2021 | $3.4M | +230.2% |
| FY2020 | -$2.6M | +44.4% |
| FY2019 | -$4.7M | +19.2% |
| FY2018 | -$5.8M | +24.7% |
| FY2017 | -$7.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RGBPP financial trends
RGBPP RevenueRGBPP Net marginRGBPP Gross profitRGBPP Gross marginRGBPP Operating incomeRGBPP Operating marginRGBPP Operating cash flowRGBPP Free cash flowRGBPP Capital expendituresRGBPP Return on equityRGBPP Stock buybacksRGBPP Dividends paidRGBPP Total assetsRGBPP Total liabilitiesRGBPP Shareholders’ equityRGBPP overview →